# Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

> **NCT02412787** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 56 (actual)

## Conditions studied

- Hunter Syndrome

## Interventions

- **DRUG:** Idursulfase-IT
- **DRUG:** Elaprase

## Key facts

- **NCT ID:** NCT02412787
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-14
- **Primary completion:** 2024-04-18
- **Final completion:** 2024-04-18
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412787, "Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02412787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*